Description: LXE408 is a novel, potent, orally bioactive and non-competitive inhibitor of kinetoplastid-selective proteasome with an IC50 of 0.04 μM for L. donovani proteasome and an EC50 of 0.04 μM for L. donovani. LXE408 has the potential for treating visceral leishmaniasis.

纯度：≥98%

CAS：1799330-15-6